Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Promega T7 RiboMAX™ Express RNAi System

The T7 RiboMAX Express RNAi System is an in vitro transcription system designed to produce milligram amounts of RNA suitable for use in RNAi assays.

Supplier:  Promega P1700

Catalog No. PRP1700


Add to cart

Includes: T7 Express Enzyme Mix; RiboMAX Express T7 2X Buffer; pGEM Express Positive Control Template; Sodium Acetate, 3.0M (pH 5.2); RNase A Solution; RQ1 RNase-free DNase; Nuclease-free Water

Description

Description

  • Produces Milligam Amounts of RNA for RNA Interference Experiments
  • siRNA duplexes for mammalian RNAi
  • Long dsRNA for nonmammalian RNAi
  • Produces milligram amounts of double-stranded RNA in 30 minutes

U.S. Patent 5,552,302.
This product is covered under license from Carnegie Institution of Washington under U.S. Patent 6,506,559, Australian Patent 743798 and other patents pending. Commercial use of this product will require a separate license from Carnegie.

Specifications

Specifications

-30°C to -10°C
Synthesis of siRNA duplexes for mammalian RNA interference, generation of large quantities of long dsRNA for non-mammalian RNA interference
100μL Enzyme mix, T7 Express (T7 RNA Polymerase, recombinant RNasin™ RNase inhibitor and recombinant inorganic Pyrophosphatase), 500μL RiboMAX™ Express T7 2X Buffer, 110U 1U/
50 x 20 μL
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit